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new insights and significantly accelerate current workflows. 
Special emphasis will be given on use cases including 4D 
PET/CT and MR Spectroscopy data - work we have done in 
cooperation with the University Hospital Freiburg and the 
Institute Claudius Regaud in Toulouse. 
(*) http://summer-project.eu/about-summer/ 
 
 
Symposium: How does the RTT world look in 2020? 
Different regions, different challenges  
 
 
SP-0605 
RTT perspective in Eastern Europe and region of Former 
Yugoslavia on basic of education an roles 
I. Curic1 
1Institute for Oncology and Radiology of Serbia, 
Radiotherapy, Belgrade, Serbia  
   
Purpose and Objective: Basic on receive and available data 
of RTT education,position, roles and titles recognized  in 
Eastren Europe situation is  more and less is almost same, in 
field of basic education, titles recognized, individualizm in 
work, research possibilities. 
Last couple years  more of countries start with application of 
Bologna system and improve the educational system in 
proffesionall studies through proffesional schools , course 
three years, or establish Faculty for Health Studies with 
possibillities for Masters postgraduates studies.But 
Radiotherapy still not recognized in field of speciallization or 
Masters postgraduate studies.  
RTT titles is still not recognized in more countries and is very 
difficult to explain – we are not same!! Even in Serbia where 
exist professional Societies , who is registered in goverment 
and recognized from National chamber, is almost inmpossible 
to put RTT titles in regulatory titles description. 
Main problem still is title recognized and failure to 
recognized in  individualizm  RTT work in main RTT skills, 
without pssibilities for reserach field of RTT. 
Materials and Methods:  For improving and accetablle vision 
of RTT  in 2020 must exist good project and cooperation 
beetwen RTT in Eastern Europe. One of good project in 
educations of RTT is ESTRO/IAEA project TTT. Through this 
project the RTT from region of Former Yugoslavia establish 
excelent cooperation in field of continual education and 
position of RTT. The members of first TTT group from this 
country actively participate in creating of education of RTT 
on schhol, chambers and proffesional Societies. Also , 
through project was made excellent connection between 
participants . 
Finaly the IAEA conference in Vienna in Decembar 2013. With 
topic about curent situation and way forward , which 
included lecturers from basic studies near the liders of 
National Societies, is good movement for future 
improvement. 
Results: This cooperation through TTT project  is get result 
in good position in international organization, possibilities to 
create one small part of education, and create documents 
about workflow and competentions for RTT in some country. 
In front of them is a responsible and difficult task to establish 
same quality education in basic studies like in they made in 
continual education. First of all to establish specialization 
and Masters studies for RTT in field of basic skils of RTT over 
Core Curiculla and one new specialization RTT Dosimetrist, 
who would be responsible for contouring and QA.Recognized 
of titles and position of RTT must provide more idividualizm 
in RTT works. 
Conclusions:  In next period the goal is   
1. provide more time for Radiotherapy subject 
through studies 
2. specialization and Masters studies in Radiotherapy 
3. RTT Dosimetrist like new skills of RTT in field of 
contouring OAR and QA 
4. Provide more individualizm in RTT work  
5. Provide possibility  of  research for RTT  
6. Cooperation beetwen proffesional Societies of 
Eastern Europe through board within ESTRO. 
  
In 2020 RTT in Eastern Europe will be technicians with 
proffessional or faculty degree, absolutely indepence in work 
with whole liability for own work with possibilites for 
research activities through its work. RTT will be RT 
Dosimetris specialist with Masters degree or specialization, 
and RTT from Esatren Europe will will share they knowledges 
through Associations. This idea is feasible.   
   
SP-0606   
Vision 2020: Challenges facing the RTT in Western Europe  
M. Leech1 
1Trinity College Dublin, Radiation Therapy, Dublin, Ireland 
Republic of  
  
It is undoubtedly an exciting but challenging time to be an 
RTT in Western Europe.  With the ever-expanding 
technological advancements in radiotherapy and the drive 
towards personalised radiotherapy for individual patients, 
RTTs in Western Europe must be equipped to meet these 
challenges. 
One such challenge is in relation to the definition of roles and 
responsibilities of the RTT and there is a wide variety in this 
at present across Western Europe.  In some countries, the 
profile of the RTT is well defined, particularly with respect to 
research, treatment planning and dosimetry, image-
guidance, clinical decision-making, ongoing care and advice 
throughout the process and psychosocial support whereas in 
others, it is less so. 
This discrepancy can be closely related to the inherent 
differences in RTT undergraduate education across Western 
Europe, with dedicated radiotherapy programmes in some 
countries and ‘mixed’ education programmes in others.   
Definition of and discrimination between standard roles, role 
expansion and advanced practice is also challenging in 
Western Europe as we approach 2020 and is somewhat 
ambiguous.  The essential competences of any graduate 
should be addressed through the undergraduate programme 
and such progression in roles and responsibilities should be 
closely linked to postgraduate education level.  
Personalised treatment is the future of radiotherapy within 
Western Europe in the next five years and this will challenge 
the RTT to examine their practice in a new fashion; moving 
from generic ‘site-based’ solutions to an individualised and 
holistic interpretation of the management and care of 
patients.   
   
SP-0607   
India How does the RTT world look in 2020? Different 
regions, different challenges 
G. Wadhawan1, G. Yadav1 
1Rajiv Gandhi Cancer Institute & Research Centre, 
Administration, Rohini Delhi, India  
   
“Emerging country like India are the fastest growing with the 
greatest needs for fast and efficient technologies to treat 
growing cancer populations” We want to make sure that what 
we develop and produce meets their needs. focused on 
learning about the clinical processes that are followed in 
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these regions, and on an effort to better understand the 
challenges that Indian RTTs face. Not surprisingly, 
emphasized some of the same issues, namely, the need to 
treat high patient volumes and the need for improved 
implementation and training, particularly when it comes to 
software.  “Clinical users in their areas deal with very high 
numbers of patients each day. They also deal with limited 
skilled resources to use, fast, and as safe as they can be 
made,”  
Our objective is to come up with a set of guidelines for the 
career pathways, job roles at different level and the 
curricula for each level of the concerned profession. India’s 
greatest challenge will be to accomplish this but: The RTT 
management structure is majorly managed by senior policy 
makers from the medical fraternity, and provides very 
little scope for Technical professionals to participate in 
policy decision making and to bring about any reforms. 
Aims to provide world of RTTs with a global standard in the 
holistic care and treatment of patients as they undergo the 
radiotherapy process with optimum radiotherapy planning & 
 treatment techniques to patients now and in the future. The 
accuracy with which each step is carried out can have an 
impact on both tumour control and normal tissue 
complications.  
These factors mandate a high degree of accuracy in 
treatment delivery which depends on RTTs how he 
implemented and uses the Technology  
However, the change in technology and the required 
technical skills in RT over the past 10 years have been 
extreme and have forced major reviews of the technical 
aspect of RTT. We believe that the outcome of this meeting 
will be very useful for strengthening the education and 
therefore the role of RTTs in India and across the Globe to 
develop & promote the profile of the RTT within the 
multidisciplinary team in different regions under different 
challenges and, bring the resolution to the 1. Evaluation of 
technology: Relevant endpoints from the perspective of the 
RTT, Are we geared to implement technology in India and 
Skills to implement technology Training programs in India. By 
2020 RTTs of India will be more numerous, better educated, 
healthier and more prosperous than at any time in our long 
history. 
    
 
Symposium with Proffered Papers: Rectal cancer: Optimal 
sequence of drugs and rays before and after surgery  
 
 
SP-0608   
Rectal cancer: optimal sequence of drugs and Xrays before 
and after surgery. What is the optimal sequence of drugs?  
R. Glynne-Jones1 
1Mount Vernon Hospital, Radiotherapy, Northwood 
Middlesex, United Kingdom  
 
Postoperative adjuvant chemotherapy is firmly established 
for patients in radically resected colon cancer with stage III 
and ‘high-risk’ stage II disease. In contrast, the debate 
continues to evolve on the benefit of postoperative adjuvant 
chemotherapy for rectal cancer patients after preoperative 
(chemo)radiation and TME surgery. Neither the indivividual 
phase III trials themselves nor the meta-analyses have 
provided a secure definitive answer for the benefit of 
postoperative adjuvant chemotherapy after SCPRT or CRT. 
Hence, several different strategies have been employed to 
escalate the intensity of chemotherapy in the neoadjuvant or 
preoperative setting.  
1) Integrating additional chemotherapy/targetted agents into 
preoperative chemoradiation (CRT) schedules 
2) Integrating induction chemo (IC) prior to CRT or short 
course preoperative radiotherapy SCPRT.    
3) Integrating induction chemo (IC) alone as an alternative to 
CRT or SCPRT. 
 
4) Integrating consolidation chemo (CC) after CRT or 
SCPRT.                                                                      
5) Alternating/interpolating chemotherapy and split course 
radiotherapy (ACAR) 
6) Combinations of the above  
These strategies are explored individually and the relevant 
trials examined.  The most frequent stragey has been 
concurrent chemoradiation and Phase III studies evaluated 
low-dose oxaliplatin (50-60mg/m2) as a radiosensitizer in 
patients with resectable cancers. This strategy increased 
acute toxicity, but showd no evidence for any consistent 
improvement in short-term endpoints such as pCR or long-
term oncological outcomes. So alternative manoevres as 
above using oxaliplatin at full systemic doses are being 
explored to see if this tactic can improve DFS or OS in 
borderline/unresectable patients where the CRM is 
compromised or cancers with high risk features for 
metastatic disease such as EMVI.  
Induction chemotherapy (IC) is a potentially useful 
therapeutic approach for locally advanced operable, 
primarily unresectable or borderline resectable rectal 
cancer. IC may be a more effective  option for patients with 
rectal cancer who would require adjuvant chemotherapy 
according to clinical and histological parameters, and MRI-
based imaging. The use of neoadjuvant systemic therapy in 
operable rectal cancer has potential advantages that include 
higher rates of sphincter-sparing surgery and the possibility 
of measuring early in-vivo response to systemic treatment. 
However, neoadjuvant treatment require a close 
collaboration between surgeons, medical oncologists, 
radiation oncologists, radiologists and pathologists.  
   
SP-0609   
What is the optimal sequence of rays?  
K. Bujko1 
1The Maria Sklodowska-Curie Memorial Cancer Center, 
Radiotherapy, Warsaw, Poland  
 
Preoperative radio(chemo)therapy is a preferable treatment 
because it is more effective and less toxic than postoperative 
radiochemotherapy. There are two schedules of preoperative 
radiotherapy: 5 x 5 Gy delivered over 5 days with immediate 
surgery used for resectable cancers and conventionally 
fractionated radiochemotherapy delivered over 5 weeks with 
surgery delayed for 6 weeks used for both resectable cancers 
and for cancers with threatened mesorectal fascia. There 
were several prospective and retrospective trials, systematic 
reviews and one meta-analysis that explored the issue of 
increasing the rest period between radiation and surgery. 
Stockholm III randomized trial that compared immediate with 
delayed surgery after 5 x 5 Gy showed a benefit in terms of 
lower rate of severe acute post-radiation toxicity in the 
immediate-surgery group. However, this benefit was 
counterbalanced by the increase in minor postoperative 
complications in the group with immediate surgery compared 
with that with delayed surgery. Long-term results are 
awaited. Regarding elderly patients who were unfit for 
chemotherapy, 5 x 5 Gy with delayed surgery produced 
favourable outcomes for cancers with threatened mesorectal 
fascia or for small cancers after full-thickness local excision. 
5 x 5 Gy and consolidation chemotherapy during a long 
